Biomarkers in Cancer Screening and Early Detection: Translational Oncology
Autor S Srivastavaen Limba Engleză Hardback – 24 aug 2017
- Offers a comprehensive, state-of-the-art perspective on the various research and clinical aspects of cancer biomarkers
- Provides immediately actionable information and hopefully also inspiration to move discovery and clinical application forward
- Offers vital knowledge to help develop personalized cancer treatment for individual patients with specific cancers
Preț: 756.49 lei
Preț vechi: 1101.75 lei
-31% Nou
144.77€ • 150.95$ • 120.32£
Carte indisponibilă temporar
Specificații
ISBN-10: 1118468805
Pagini: 320
Dimensiuni: 179 x 260 x 22 mm
Greutate: 0.91 kg
Editura: Wiley
Seria Translational Oncology
Locul publicării:Hoboken, United States
Public țintă
Primary audience: Clinical and research oncologists; oncology fellow and students; medical residents and students, pharmacologic research and development professionals, biomedical scientists (∼500,000 people worldwide) Secondary audience: Generalist physicians treating cancer patients; other professionals in health care (oncology counselors, nurses, etc.); other medical scientists (∼1,000,000 people worldwide).Cuprins
Notă biografică
Edited by
Sudhir Srivastava, Ph.D., MPH Senior Scientific Officer, Chief, Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Translational Oncology Series
Series Editors
ROBERT C. BAST, MD, Vice President for Translational Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
MAURIE MARKMAN, MD, Senior Vice President for Clinical Affairs, Cancer Treatment Centers of America, Clinical Professor of Medicine, Drexel University College of Medicine, Philadelphia, PA, USA
ERNEST HAWK, MD, MPH, Vice President, Division of OVP, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA